MedPath

The effectiveness of endocrine disorders therapy in depression improvement of HIV infected me

Phase 2
Conditions
HIV infected people.
Unspecified human immunodeficiency virus [HIV] disease
Registration Number
IRCT2013071914054N1
Lead Sponsor
vice chancellor for research of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
104
Inclusion Criteria

HIV+ confirmed by Western Blot; Patient on ART treatment; beck questionnaire with score>21
Exclusion criteria: Consumption of antidepressant drugs; Confirmed endocrine disorder ; Any sign of infectious disease such as fever; Opportunistic infections; addiction; Major depression with suicidal attempt or emotional events in last month.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression. Timepoint: Detection of depression before and after intervention. Method of measurement: Beck questionnaire.
Secondary Outcome Measures
NameTimeMethod
Endocrine lab tests: TSH,T3RU,T4,T3,ACTH,UFC, plasmacortisol ,PRL,LH,FSH, freeTestosterone. Timepoint: Before and after intervention. Method of measurement: Laboratory tests.
© Copyright 2025. All Rights Reserved by MedPath